Customize
Quick Links
Past Events

Accreditation/
Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 22.0 Contact Hours.


Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for a maximum of 22.0 contact hours (0.22 CEUs).

Acknowledgment of Commercial Support

This activity is supported by educational grants from Ariad Pharmaceuticals, Inc., AstraZeneca, Celgene Corporation, Clovis Oncology, Eisai, Exelixis, Inc., Genomic Health, Inc., Incyte, Lilly, Medivation, Inc., Merck, NantHealth, Inc., Novartis Pharmaceuticals Corporation, Novocure Inc., Pfizer, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Taiho Oncology, Inc., Takeda Oncology, Tesaro, and Teva Pharmaceuticals.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.



The Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® is wholly owned and operated by PER Events, LLC, an affiliate of Physicians' Education Resource®.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

34th Annual CFS Chemotherapy Foundation Satellite Symposium

34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®


Thursday, November 10, 2016
8:30 AM - 10:00 AM
CME-Certified Concurrent Symposium - Live Taping: Leveraging New Evidence in the Context of Evolving Early-Stage Treatment Standards in HER2-Positive Breast Cancer

New York Marriott Marquis
1535 Broadway
New York, NY 10036
Room: Julliard Complex (5th Floor)

 

Registration

Registration is complimentary, but seating is limited. Please register here.
 
 
Overview

This edition of Medical Crossfire®, filmed in conjunction with the 34th Annual CFS Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®, is designed to provide a dynamic review of current and evolving paradigms in the treatment of HER2-positive breast cancer, including therapeutic decision making in the adjuvant setting, biomarkers, extended adjuvant therapy, and management of treatment-related toxicities.

Our activity chair, Joyce O'Shaughnessy, MD, and our expert faculty, William J. Gradishar MD, FASCO, FACP; Mark Pegram, MD; and Linda T. Vahdat, MD, MBA, will emphasize the cutting-edge clinical research shaping how clinicians treat HER2-positive breast cancer now and how they will in the not-too-distant future.

The activity will include 2 segments: one on critical evaluation of landmark trials and the need for more effective adjuvant approaches and another on how emerging strategies can improve outcomes for patients with early stage HER2-positive breast cancer. Each segment will start with a brief didactic overview before leading into an extensive panel discussion led by Dr. O’Shaughnessy. This extended discussion format will allow ample time for examining the nuances and challenges faced by clinicians in everyday practice and include a discussion of strategies for applying emerging data to clinical practice to improve outcomes for patients. The activity will conclude with an interactive question-and-answer session, followed by an evidence-based summary of the morning’s discussion.

Target Audience

This educational activity is intended for medical oncologists, pathologists, and fellows who treat patients with cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer are also invited to participate.

Educational Objectives
  • Review landmark and recent trial data, along with unmet needs in the area of adjuvant therapy for HER2-positive breast cancer
  • Discuss the application of biomarkers, molecular assays, and other risk-assessment tools in treatment decision making for HER2-positive breast cancer
  • Explain current standards and emerging approaches for the management of toxicities associated with extended adjuvant treatment of HER2-positive breast cancer
  • Apply strategies for individualized treatment planning based upon efficacy and safety data, as well as patient and disease characteristics
 
Activity Chair



Joyce A. O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
Co-Chair Breast Cancer Research Program
The US Oncology Network
                                  Dallas, TX
 

Faculty



William J. Gradishar, MD, FASCO, FACP
Betsy Bramsen Professor of Breast Oncology & Professor of Medicine
Deputy Director, Clinical Network
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
                                  Director, Maggie Daley Center for Women's Cancer Care
                                  Deputy Chief, Davison of Hematology/Oncology
                                  Northwestern University Feinberg School of Medicine
                                  Chicago, IL


Mark Pegram, MD
Stanford Cancer Institute 


Linda Vahdat
Professor of Medicine

Weill Cornell Medicine
 


Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Aknowledgement of Commercial Support

This activity is supported by an educational grant from Puma Biotechnology.
 

Photos from the 34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®















Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
293031
Filter By